Recognizing and managing obstructive sleep apnea in primary care

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 11, Issue 6, 2009, Pages 330-338

  Culpepper, Larry ^a   Roth, Thomas ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARMODAFINIL; MODAFINIL; PLACEBO;

ADENOIDECTOMY; BECK DEPRESSION INVENTORY; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONSERVATIVE TREATMENT; CRANIOFACIAL SURGERY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG EFFICACY; EARLY DIAGNOSIS; HUMAN; LIFESTYLE; MEDICAL DECISION MAKING; PATIENT ASSESSMENT; PATIENT EDUCATION; PATIENT MONITORING; PHYSICIAN ATTITUDE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIMARY MEDICAL CARE; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; SOMNOLENCE; TONSILLECTOMY; TRACHEOSTOMY;

EID: 77957687571     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.08m00725     Document Type: Review

References (84)

1. Terán-Santos J, Jiménez-Gómez A, Cordero-Guevera J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med. 1999;340(11):847-851.
2. Sassani A, Findley LJ, Kryger M, et al. Reducing motor-vehicle collisions, costs and fatalities by treating obstructive sleep apnea syndrome. Sleep. 2004;27(3)453-458.
3. Ulfberg J, Carter N, Edling C. Sleep-disordered breathing and occupational accidents. Scand J Work Environ Health. 2000;26(3):237-242.
4. Sforza E, De Saint Hilaire Z, Pelissolo A, et al. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med. 2002;3(2):139-145.
5. Sharafkhaneh A, Giray N, Richardson P, et al. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep. 2005;28(11): 1405-1411.
6. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the US Preventive Service Task Force. Ann Intern Med. 2002;136(10):765-776.
7. Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry. 2003;64(10): 1195-1200.
8. Hashmi AM, Giray N, Hirshkowitz M. Sleep-related breathing disorders and mood disorders. Sleep Med Clin. 2006;1(4):513-517.
9. Schwartz DJ, Karatinos G. For individuals with obstructive sleep apnea, institution of CPAP therapy is associated with an amelioration of symptoms of depression which is sustained long term. J Clin Sleep Med. 2007; 3(6):631-635.
10. Peppard PE, Szklo-Coxe M, Hla KM, et al. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med. 2006; 166(16):1709-1715.
11. Bardwell WA, Moore P, Ancoli-Israel S, et al. Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity? Am J Psychiatry. 2003;160(2):350-355.
12. Basta M, Lin HM, Pejovic S, et al. Lack of regular exercise, depression, and degree of apnea are predictors of excessive daytime sleepiness in patients with sleep apnea: sex differences. J Clin Sleep Med. 2008;4(1): 19-25.
13. Akashiba T, Kawahara S, Akahoshi T, et al. Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest. 2002;122(3):861-865.
14. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17): 1230-1235.
15. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men, 1: prevalence and severity. Am J Respir Crit Care Med. 1998; 157(1):144-148.
16. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-1239.
17. Pagel JF. The burden of obstructive sleep apnea and associated excessive sleepiness. J Fam Pract. 2008;57(suppl 8):S3-S8.
18. Dancey DR, Hanly PJ, Soong C, et al. Gender differences in sleep apnea: the role of neck circumference. Chest. 2003;123(5):1544-1550.
19. Davies RJ, Stradling JR. The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnea syndrome. Eur Respir J. 1990;3(5):509-514.
20. Flemons WW. Clinical practice: obstructive sleep apnea. N Engl J Med. 2002;347(7):498-504.
21. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284(23): 3015-3021.
22. Sanders MH, Givelber RJ. Overview of obstructive sleep apnoea in adults. In: Lee-Chong, ed. Sleep Disorders: A Brief Guide. Chichester, UK: John Wiley and Sons; 2007:39-57
23. Scottish Intercollegiate Guidelines Network. Management of Obstructive Sleep Apnoea/Hypopnoea Syndrome in Adults: A National Clinical Guideline. Edinburgh, UK: Scottish Intercollegiate Guidelines Network; 2003:73.
24. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med. 2002;162(8):893-900.
25. Institute for Clinical Systems Improvement. Health Care Guideline; Diagnosis and Treatment of Obstructive Sleep Apnea; 2008. http://www.icsi.org/sleep_apnea/sleep_apnea__diagnosis_and_treatment_of_obstructive_.html. Accessed November 2, 2009
26. Schröder CM, O'Hara R. Depression and obstructive sleep apnea (OSA). Ann Gen Psychiatry. 2005;4:13.
27. Doghramji PP. Recognition of obstructive sleep apnea and associated excessive sleepiness in primary care. J Fam Pract. 2008;57(suppl 8):S17-S23.
28. Rakel RE. Recognition and diagnosis of excessive daytime sleepiness from a primary care perspective. Consultant. 2007;47(suppl 10):22-30.
29. Skjodt NM, Atkar R, Easton PA. Screening for hypothyroidism in sleep apnea. Am J Respir Crit Care Med. 1999;160(2):732-735.
30. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. Chest. 1993;103(1):30-36.
31. Carskadon MA, Dement WC, Mitler MM, et al. Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness. Sleep. 1986;9(4):519-524.
32. Mitler MM, Gujavarty KS, Browman CP. Maintenance of Wakefulness Test: a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol. 1982;53(6):658-661.
33. Collop NA, Anderson WM, Boehlecke B, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. J Clin Sleep Med. 2007;3(7)737-747.
34. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862-865.
35. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006; 29(3):375-380.
36. Meurice JC, Dore P, Paquereau J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest. 1994;105(2):429-433.
37. Pieters T, Collard P, Aubert G, et al. Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J. 1996;9(5):939-944.
38. Bazzano LA, Khan Z, Reynolds K, et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2)417-423.
39. Egea CJ, Aizpuru F, Pinto JA, et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Med. 2008;9(6):660-666.
40. Gay P, Weaver T, Loube D, et al. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep. 2006; 29(3)381-401.
41. Giles TL, Lasserson TJ, Smith BH, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;(3):CD001106.
42. Patel SR, White DP, Malhotra A, et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med. 2003;163(5):565-571.
43. de Hoyos A, Liu PP, Bernard DC, et al. Haemodynamic effects of continuous positive airway pressure in humans with normal and impaired left ventricular function. Clin Sci (Lond). 1995;88(2):173-178.
44. Montner PK, Greene ER, Murata GH, et al. Hemodynamic effects of nasal and face mask continuous positive airway pressure. Am J Respir Crit Care Med. 1994;149(6):1614-1618.
45. Leech JA, Ascah KJ. Haemodynamic effects of nasal CPAP examined by Doppler echocardiography. Chest. 1991;99(2):323-326.
46. Liston R, Deegan PC, McCreery C, et al. Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J. 1995;8(3):430-435.
47. Sharkey RA, Mulloy EM, Long M, et al. The effect of continuous positive airway pressure (CPAP) on renal vascular resistance: the influence of renal denervation. Crit Care. 1999;3(1):33-37.
48. Engleman HM, Cheshire KE, Deary IJ, et al. Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax. 1993;48(9): 911-914.
49. Engleman HM, Martin SE, Deary IJ, et al. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax. 1997;52(2):114-119.
50. Means MK, Lichstein KL, Edinger JD, et al. Changes in depressive symptoms after continuous positive airway pressure treatment for obstructive sleep apnea. Sleep Breath. 2003;7(1):31-42.
51. Sánchez AI, Buela-Casal G, Bermúdez MP, et al. The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. Psychiatry Clin Neurosci. 2001;55(6):641-646.
52. Krahn LE, Miller BW, Bergstrom LR. Rapid resolution of intense suicidal ideation after treatment of severe obstructive sleep apnea. J Clin Sleep Med. 2008;4(1):64-65.
53. Borak J, Ciéslicki JK, Koziej M, et al. Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J Sleep Res. 1996;5(2):123-127.
54. Henke KG, Grady JJ, Kuna ST. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome: a randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2001;163(4):911-917.
55. Muñoz A, Mayoralas LR, Barbé F, et al. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J. 2000;15(4):676-681.
56. Yu BH, Ancoli-Israel S, Dimsdale JE. Effect of CPAP treatment on mood states in patients with sleep apnea. J Psychiatr Res. 1999;33(5):427-432.
57. Millman RP, Fogel BS, McNamara ME, et al. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry. 1989;50(9):348-351.
58. Yue W, Hao W, Liu P, et al. A case-control study on psychological symptoms in sleep apnea-hypopnea syndrome. Can J Psychiatry. 2003; 48(5)318-323.
59. McArdle N, Devereux G, Heidarnejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159(4, pt 1):1108-1114.
60. Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007;30(6):711-719.
61. Edinger JD, Carwile S, Miller P, et al. Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnea. Percept Mot Skills. 1994;78(3, pt 2):1116-1118.
62. American Sleep Apnea Association. If Your Patient Is Not Complying With CPAP; 2007. http://www.sleepapnea.org/info/practitioner/cpappatient.html.
63. Neill AM, Wai HS, Bannan SP, et al. Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. Eur Respir J. 2003; 22(2):258-262.
64. American Sleep Apnea Association. Education Bulletin: Choosing a CPAP; 2005. http://www.sleepapnea.org/resources/pubs/cpap.htm.
65. George PT. Selecting sleep-disordered breathing appliances: biomechanical considerations. J Am Dent Assoc. 2001;132(3):339-347.
66. Lim J, Lasserson TJ, Fleetham J, et al. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev. 2006;(1):CD004435.
67. Gotsopoulos H, Chen C, Qian J, et al. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med. 2002;166(5):743-748.
68. Chan AS, Lee RW, Cistulli PA. Dental appliance treatment for obstructive sleep apnea. Chest. 2007;132(2):693-699.
69. Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep. 1996;19(2):156-177.
70. Mitchell RB, Kelly J. Outcomes and quality of life following adenotonsillectomy for sleep-disordered breathing in children. ORL J Otorhinolaryngol Relat Spec. 2007;69(6):345-348.
71. Ballard RD. Management of patients with obstructive sleep apnea. J Fam Pract. 2008;57(suppl 8):S24-S30.
72. Li KK. Surgical therapy for obstructive sleep apnea syndrome. Semin Respir Crit Care Med. 2005;26:80-88.
73. Senders CW, Strong EB. The surgical treatment of obstructive sleep apnea. Clin Rev Allergy Immunol. 2003;25:213-220.
74. Sundaram S, Bridgman SA, Lim J, et al. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev. 2005;(4):CD001004.
75. Höijer U, Ejnell H, Hedner J, et al. The effects of nasal dilation on snoring and obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 1992;118(3):281-284.
76. Morgenthaler TI, Kapen S, Lee-Chiong T, et al. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep. 2006;29(8): 1031-1035.
77. Veasey SC, Guilleminault C, Strohl KP, et al. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 2006;29(8):1036-1044.
78. Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure treated obstructive sleep apnea/hypopnea syndrome. Sleep. 2005;28(4):464-471.
79. Hirshkowitz M, Black JE, Wesnes K, et al. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med. 2007;101(3):616-627.
80. Roth T, White D, Schmidt-Nowara W, et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther. 2006;28(5):689-706.
81. Kingshott RN, Vennelle M, Coleman EL, et al. Randomized, doubleblind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 2001;163(4):918-923.
82. Pack AI, Black JE, Schwartz JR, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med. 2001;164(9):1675-1681.
83. Schwartz JR, Hirshkowitz M, Erman MK, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest. 2003;124(6):2192-2199.
84. Roth T, Rippon GA, Arora S. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea. Sleep Breath. 2008; 12(1):53-62.